Literature DB >> 27783862

Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation.

Hiroshi Kaji1.   

Abstract

Adipose tissue has recently been reevaluated as an endocrine organ, and adipose-tissue-derived endocrine factors are termed adipokines. Plasminogen activator inhibitor-1 (PAI-1) is the primary inhibitor of PAs, which convert plasminogen into plasmin, a critical protease involved in fibrinolysis. PAI-1 induces fibrinogenesis by suppressing intravascular and tissue fibrinolysis. Moreover, PAI-1 exerts various cellular effects independently of fibrinolysis. Although PAI-1 is expressed in various tissues, its expression is regulated by numerous growth factors, cytokines, and hormones in a paracrine and endocrine manner. Adipocyte-derived PAI-1, predominantly expressed in visceral fat, is released into the circulation in parallel with increased fat mass, and it functions as a crucial adipokine that negatively affects physiological metabolism and vascular biology. Elevated PAI-1 levels induce insulin resistance and metabolic abnormalities during proinflammatory processes involving several cytokines and chemokines in diabetes. Several studies have indicated that PAI-1 plays crucial roles in insulin actions on liver, muscle, and fat. Accumulated fat and enhanced adipose tissue-derived PAI-1 influence metabolism and vessels in relation to macrophage infiltration, chronic inflammation, and free fatty acid release in obese states. PAI-1-induced fibrinolysis abnormalities are associated with metabolic syndrome, leading to cardiovascular disease through dysregulated vascular coagulation, endothelial dysfunction, and metabolic abnormalities. Adipose tissue-derived PAI-1 is involved in insulin resistance, osteoporosis, and sarcopenia induced by glucocorticoid excess in mice. Moreover, PAI-1 is involved in the other pathological states, such as nonalcoholic fatty liver disease, and cancer. As such, PAI-1 may be exploited as a marker of disease activity as well being a target for clinical drug development. © 2016 American Physiological Society. Compr Physiol 6:1873-1896, 2016.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27783862     DOI: 10.1002/cphy.c160004

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  30 in total

Review 1.  Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update.

Authors:  Todd Hulgan
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

Review 2.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

Review 3.  Molecular insights into the interplay between adiposity, breast cancer and bone metastasis.

Authors:  Sneha Soni; Meaghan Torvund; Chandi C Mandal
Journal:  Clin Exp Metastasis       Date:  2021-02-16       Impact factor: 5.150

Review 4.  Adipokines, adiposity, and atherosclerosis.

Authors:  Longhua Liu; Zunhan Shi; Xiaohui Ji; Wenqian Zhang; Jinwen Luan; Tarik Zahr; Li Qiang
Journal:  Cell Mol Life Sci       Date:  2022-05-03       Impact factor: 9.261

5.  Adipose-Derived Inflammatory and Coagulant Mediators in Patients With Sepsis.

Authors:  Brittany A Zwischenberger; Beverly K Balasuriya; Dwight D Harris; Nisha Nataraj; Allison M Owen; Maria E C Bruno; Sujata Mukherjee; Victor Ortiz-Soriano; William O'Connor; Chenlu Ke; Arnold J Stromberg; Phillip K Chang; Javier A Neyra; Hiroshi Saito; Marlene E Starr
Journal:  Shock       Date:  2021-05-01       Impact factor: 3.454

6.  No Sweetie Pie: Newly Uncovered Role for PAI (Plasminogen Activator Inhibitor)-1 in Inflammatory Responses to Ischemia/Reperfusion.

Authors:  William P Fay; Ronald J Korthuis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-04       Impact factor: 10.514

7.  Improvement in the cardiovascular profile of patients with morbid obesity following bariatric surgery: Effect on hypercoagulability.

Authors:  Ana Marco; Pascual Marco
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

8.  Visceral fat-specific regulation of plasminogen activator inhibitor-1 in aged septic mice.

Authors:  Maria E C Bruno; Sujata Mukherjee; Arnold J Stromberg; Hiroshi Saito; Marlene E Starr
Journal:  J Cell Physiol       Date:  2021-08-09       Impact factor: 6.384

9.  Plasminogen activator inhibitor-1 deficiency enhances subchondral osteopenia after induction of osteoarthritis in mice.

Authors:  Akihiro Moritake; Naoyuki Kawao; Kiyotaka Okada; Kohei Tatsumi; Masayoshi Ishida; Katsumi Okumoto; Osamu Matsuo; Masao Akagi; Hiroshi Kaji
Journal:  BMC Musculoskelet Disord       Date:  2017-09-11       Impact factor: 2.362

10.  APX3330 Promotes Neurorestorative Effects after Stroke in Type One Diabetic Rats.

Authors:  Tao Yan; Poornima Venkat; Michael Chopp; Alex Zacharek; Peng Yu; Ruizhuo Ning; Xiaoxi Qiao; Mark R Kelley; Jieli Chen
Journal:  Aging Dis       Date:  2018-06-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.